Continuous positive airway pressure (CPAP) therapy is currently the first line non-surgical treatment when a patient is diagnosed with obstructive sleep apnea (OSA).
Stanford scientists have developed a thin, wearable electrode array patch capable of non-invasively recording high-resolution electrical signals through the skin of the body's internal organs, offering a new window into physiological processes that have historically been diffi
Researchers in Prof. Mark Schnitzer's laboratory have developed a robotic optical microscopy system which enables users to simultaneously view and record separate areas of a single three-dimensional sample.
Imaging methods that can visualize biological samples with high and temporal resolution are critical for modern biomedical research and clinical practice.
Stanford researchers have developed a personalized arrhythmia risk prediction tool for dilated cardiomyopathy (DCM) patients using patient-derived induced pluripotent stem cells (iPSCs) to replicate heart biology and accurately predict arrhythmia risk, enabling timely interven
Stanford scientists have discovered novel high molecular weight isoforms of thymic stromal lymphopoietin (TSLP), measured using nanoimmunoassay (NIA), that can serve as a blood-based biomarker for the diagnosis and prognostication of acute graft versus host disease (aGVHD).
Researchers from Stanford have developed a novel topical pharmaceutical composition comprising of a chemical inhibitor encapsulated in nanomicelles for the treatment of vision loss associated with acute optic neuropathies.
Researchers at Stanford, in collaboration with UCSF, have developed a two-part approach to preventing preterm birth (PTB), the leading cause of infant mortality worldwide. Current treatments, like low-dose aspirin and progesterone, are limited and often ineffective.
Researchers at Stanford University have developed a compact insulin pump for continuous subcutaneous insulin infusion (CSII) that addresses a core limitation of many commercial pumps: device size driven by piston-based mechanics.
Researchers at Stanford have created the first small primate model to study human heart rhythm disorders and also discovered a new way the heart keeps its beat.
Over 1 in 3 people are affected by neurological conditions worldwide. Pharmacological and surgical treatment options may be limited due to access, side effects, and reduced therapeutic efficacy.
Stanford University researchers in the Bamm and Durmus Labs have developed the Dynamic AI-Driven Raman Techniques (DART) platform, which integrates electrochemical enhancement with surface-enhanced Raman spectroscopy for real-time, sensitive, specific, reproducible biomarker d
Stanford researchers have developed a new therapeutic approach to protect neurons and promote axon regeneration by restoring mitochondrial transport within axons, a key process disrupted in many neurodegenerative diseases.